Petros Pharmaceuticals, Inc.
PTPI
$0.01
$0.001.41%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.14M | 6.07M | 7.32M | 8.93M | 1.72M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 26.90K | 63.20K | 75.30K | 53.40K | 900.00 |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 5.48M | 5.57M |
| Total Current Assets | 5.16M | 6.13M | 7.40M | 14.47M | 7.29M |
|
|
|||||
| Total Current Assets | 5.16M | 6.13M | 7.40M | 14.47M | 7.29M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 3.14M | 3.34M |
| Total Assets | 5.16M | 6.13M | 7.40M | 17.61M | 10.64M |
|
|
|||||
| Total Accounts Payable | 83.90K | 421.10K | 970.00K | 756.70K | 764.30K |
| Total Accrued Expenses | 142.50K | 512.00K | 260.60K | 199.70K | 99.60K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 2.07M | 1.83M | 1.72M | 26.18M | 17.16M |
| Total Other Current Liabilities | 2.07M | 1.83M | 1.72M | 26.18M | 17.16M |
| Total Current Liabilities | 2.29M | 2.77M | 2.95M | 27.13M | 18.03M |
|
|
|||||
| Total Current Liabilities | 2.29M | 2.77M | 2.95M | 27.13M | 18.03M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 57.60K | 75.20K |
| Total Liabilities | 2.29M | 2.77M | 2.95M | 27.19M | 18.10M |
|
|
|||||
| Common Stock & APIC | 114.17M | 114.33M | 114.48M | 105.88M | 105.74M |
| Retained Earnings | -111.29M | -110.96M | -110.04M | -115.47M | -113.21M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 2.87M | 3.37M | 4.45M | -9.58M | -7.47M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.87M | 3.37M | 4.45M | -9.58M | -7.47M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.87M | 3.37M | 4.45M | -9.58M | -7.47M |
|
|
|||||